Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
4.150
+0.200 (5.06%)
Jun 20, 2024, 1:51 PM EDT - Market open

Eagle Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20222021202020192018 2017 - 2012
Market Capitalization
54380658607821601
Upgrade
Market Cap Growth
--42.14%8.37%-26.12%36.70%-24.62%
Upgrade
Enterprise Value
107388586537750566
Upgrade
PE Ratio
4.4510.67-76.2250.6157.3918.83
Upgrade
PS Ratio
0.201.203.833.234.192.82
Upgrade
PB Ratio
0.211.633.733.264.583.74
Upgrade
P/FCF Ratio
-27.107.5323.5712.4514.8811.50
Upgrade
P/OCF Ratio
-27.317.5023.3012.2614.6711.47
Upgrade
EV/Sales Ratio
0.421.223.412.863.832.66
Upgrade
EV/EBITDA Ratio
1.884.92309.3117.8825.5714.01
Upgrade
EV/EBIT Ratio
3.055.92-201.0021.2630.3915.40
Upgrade
EV/FCF Ratio
-32.947.6720.9911.0113.5910.84
Upgrade
Debt / Equity Ratio
0.280.270.150.180.220.28
Upgrade
Debt / EBITDA Ratio
1.230.7913.531.101.311.10
Upgrade
Debt / FCF Ratio
-7.471.240.920.680.700.85
Upgrade
Quick Ratio
1.511.151.874.054.063.66
Upgrade
Current Ratio
2.161.702.324.364.624.13
Upgrade
Asset Turnover
0.640.850.660.670.760.83
Upgrade
Interest Coverage
5.7916.19-1.789.809.1913.44
Upgrade
Return on Equity (ROE)
5.00%15.50%-4.60%6.60%8.10%17.80%
Upgrade
Return on Assets (ROA)
3.00%9.50%-3.30%4.30%5.50%12.40%
Upgrade
Return on Capital (ROIC)
5.21%15.87%1.37%7.95%6.52%16.38%
Upgrade
Earnings Yield
22.72%9.37%-1.31%1.98%1.74%5.31%
Upgrade
FCF Yield
-17.86%13.28%4.24%8.03%6.72%8.70%
Upgrade
Buyback Yield / Dilution
-2.48%-0.11%5.23%2.60%7.46%3.96%
Upgrade
Total Shareholder Return
-2.48%-0.11%5.23%2.60%7.46%3.96%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).